Aubagio® significantly reduced risk of new clinical relapse or MRI lesion in multiple sclerosis study
Genzyme, 3 Oct 2013
Accessed on 5 Oct 2013 from http://news.genzyme.com/press-release/aubagio-significantly-reduced-risk-new-clinical-relapse-or-mri-lesion-multiple-scleros.